20/20 HealthCare Partners (HCP) LLC

www.2020hcp.com

Foreign Investment Company

Tech Verticals Preferences

Biotechnology, Digital Health, Healthtech, Medical Devices, MedTech, Pharmaceuticals

General Data

Established	2002
Current Active Portfolio Companies:	2

DESCRIPTION

20/20 HealthCare Partners LLC (20/20HCP) provides equity financing for promising growth businesses as well as for buyouts or recapitalizations of established companies specializing in the Medical-Technology industry. We work with management to streamline product development, regulatory approval and market penetration. Our industry experienced professionals are able to introduce portfolio companies to strategic partnerships. By doing so, we expedite the product development cycle and shorten the time to market – and increase company value for further investment, buyout, public offering or other exit.

CONTACT INFO

Expand / Collapse All

Main Address: Auburndale, United States

Address	2000 Commonwealth Ave., Suite 200
City	Auburndale
State/Province	MA
Country	United States

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Hillel Bachrach	Managing Partner

Preferences

Type of Financing	Equity
Stage Preferences	Initial Revenues,Revenue Growth
Phase Preferences	Clinical Trials,FDA Approved,Phase II,Phase III

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

50%

Digital Health

50%

	PORTFOLIO COMPANIES

Current Portfolio Companies (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Variantyx

Biomed

Fourth Round - Extended	17/02/2024	N/A	$21m
Fourth Round	19/10/2023	N/A	$15m
Third Round - Extended	14/02/2022	N/A	$41.5m
Third Round	16/03/2021	N/A	$20m
Second Round	05/06/2019	N/A	$10m
First Round	01/04/2017	N/A	$6m

XRHealth

Dig. Health

Fourth Round	09/01/2024	N/A	$6m
Third Round	28/02/2022	N/A	$10m
Second Round	03/06/2021	N/A	$9m
First Round - Extended	22/04/2020	N/A	$7m
Seed - Extended	06/08/2017	N/A	$3.3m

Exits (2)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	08/08/2019	abCDe	The transaction is expected to close in the Q4/2019, subject to approval by Corindus stockholders, the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, and the satisfaction of other customary closing conditions.
abC Defghij	Acquired	01/01/2018	abCDe

Historic Portfolio (1)